Search
177Lu-NI-FAPI
go.drugbank.com/drugs/DB33977Experimental177Lu-NI-FAPI is a small molecule drug. 177Lu-NI-FAPI is under investigation in clinical trial NCT07822347 (Research on NI-FAPI-04 for the Treatment of Hypoxic and Fibroblast Activation Protein Related
Synonyms: 177Lu-NI-FAPISwertia japonica whole flowering
go.drugbank.com/drugs/DB14268InvestigationalSwertia japonica whole flowering is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Ginkgo biloba leaf oil
go.drugbank.com/drugs/DB14285InvestigationalGinkgo biloba leaf oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Panax ginseng root oil
go.drugbank.com/drugs/DB14286InvestigationalPanax ginseng root oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Isospaglumic acid
go.drugbank.com/drugs/DB19650InvestigationalIsospaglumic acid is a small molecule drug. … Isospaglumic acid is under investigation in clinical trial NCT06800274 (Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film Dysfunction).
Synonyms: N-acetylaspartylglutamic acidGlovadalen
go.drugbank.com/drugs/DB21709InvestigationalGlovadalen is under investigation in clinical trial NCT06970301 (A Study to Assess the Safety and Tolerability, and Pharmacokinetics of UCB0022 in Healthy Caucasian, Japanese, and Chinese Participants) … Glovadalen is a small molecule drug.
Geneticin
go.drugbank.com/drugs/DB04263ExperimentalGeneticin blocks polypeptide synthesis by inhibiting the elongation step in both prokaryotic and eukaryotic cells and is commonly used in laboratory research to select genetically engineered cells. … Geneticin (also known as G418) is an aminoglycoside antibiotic similar in structure to gentamicin B1, produced by Micromonospora rhodorangea.
Camibirstat
go.drugbank.com/drugs/DB21586InvestigationalCamibirstat is a small molecule drug. … Camibirstat is under investigation in clinical trial NCT04891757 (FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies).